Clinical Trial Update: MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial update for MCLA-128 in combination with trastuzumab/chemotherapy in HER2-positive breast cancer and with endocrine therapy in ER-positive, low-HER…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• MCLA-128
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Merus B.V. | Conditions: Breast Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2024-03-07